May 19th 2020
Noxopharm receives FDA green light to progress towards Veyonda® trial
May 5th 2020
G Medical continues expansion, receiving TGA approval for GMP
April 8th 2020
Non-elective treatment profile provides Avita Medical with income stability
March 30th 2020
Genetic Signatures builds on SARS technology
Connect with us
Subscribe for updates on our small cap, ASX listed biotech portfolio.
Thanks for subscribing!